Cite

    Nakamura, T. et al. (2022). End‐of‐life impact of concurrent diabetes mellitus and adrenal insufficiency as immune‐related adverse events in an advanced non‐small cell lung cancer patient. Thoracic cancer. 13 (21), pp. 3073-3075. [Online].